Member Info for researcher1

just bought another 5000 shares as well - average down in the 70s now - who would have thought it possible, with the directors all paying £1.10 themselves...

not sure I agree sunny - stress-selling is going to crucify a share even if the news is good - much better in fact to line up the good news to coincide with the end of sustained share-dumping, thus allowing the Sp to quickly return to levels that reflect the IP and revenue potential.

Excellent trial update - I'm very excited about the use of P. in prostate diagnosis - absolutely one of those cancers that liquid biopsy can get on top of through regular pain-free testing....

Matrix, when there is a distressed seller about, news makes very little difference - it simply provides a short-lived rise for them to sell into. This happened last year with Angle too. They sat on news whilst the stress-seller disposed of an enormous holding, driving the SP to all-time lows, then the share price rapidly doubled, supported by regular news release, as soon as the seller ended (it has tripled now). Stay calm.

7. end of share stress-selling

yes true Sang - we can stop this by positioning large sell limit orders (at a suitably high price) - it prevents shorters from borrowing them....

well, he gave me the opportunity of a huge double-down this morning at just over 70p (so average is now 82p).
I did the same with Angle as it crashed to 40p when Jupiter were forced to sell all their holding, and got my average down to 46p - it's now 120.... happy days.....

indeed crusty, only recently the SP hit 93 allowing him to begin selling this lot....but let's see how many Holdings RNSs we get....

Malachi - it wasn't me who said you were wrong... in fact I think you are right, partly... :-)

yes , why not yuyus, if you can be bothered by then. It's typical Daily Mail headline grabbing, no substance.

Agent, we've been through all this before. Parsortix is not a broad diagnostic, but a tool to capture live CTCs in an individual in order to precisely locate the source and type of a cancer and to fine-tune a treatment. It will work perfectly downstream from the likes of Galleri and/or Grail.

totally with you there BTHF - though perhaps not the 'forever' part - some top-slicing at £4 then £8 for me - though the remainder will be held for a long time I intend.

the company announced an upgrade some months ago, but will be waiting for FDA approval first, as the new machine will need (fast track) approval as well....

Parsortix is indeed being upgraded and improved. As I understand it, the new version will go through a fast track FDA approval (£500K) once ready - BUT I assume Angle will wait for current FDA response first...

you can look at it that way Emerald (though many SPs have fallen below a placing), but better to think ahead to Parsortix global roll out - it will save you worrying about a few pence here and there....

many of us will have lower averages Crisp, as a result of piling in at around 40p, when Jupiter were stress-selling, but any average around the 116p mark (paid recently by iis) is an excellent position for future growth.

why bother commenting then Neutral (surely a misnomer?)? If you can't see the benefit to the environment and the potential thereof, what are you doing here? I'm back in as of today.

and we'd all read it a few days ago :-)

isthisawinner we did know that this report was coming, hence little SP action ....

looks like the MMs want to keep the lid on for the moment....